Approval · Notice of Compliance 30630 · 2023
LEMTRADA: Notice of Compliance 30630
Issued May 4, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30630
- Date
- May 4, 2023
- Company
- Sanofi Genzyme, A Division Of Sanofi-Aventis Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEMTRADA | Not yet assigned | — |
Medicinal ingredients
- ALEMTUZUMAB 12 MG per 1.2ML